Ukukhathazeka okuvamile okudidanisa abantu abaningi kungakhathaliseki ukuthi iphilisi yokusalela ekuseni noma cha ( Hlela B isinyathelo esisodwa ) kuyinto efanayo nephilisi yokukhipha isisu ( RU486 ). Lokhu kudideka kubangelwa izinkolelo ezingalungile mayelana nokukhulelwa okuphuthumayo . Kubalulekile ukuqaphela ukuthi le mithi emibili isebenza ngezinhloso ezahlukene futhi isebenza ngokuhluke kakhulu komunye nomunye.
Iyini iPilisi Ngemuva?
Iphilisi elandela ekuseni iyindlela yokuvimbela i-hormonal . Uma kuthathwa amahora angama-72 wezocansi ezingavimbelwe noma ukwehluleka kokukhulelwa , kungasiza ekuvimbeleni ukukhulelwa. Iphilisi elandela ekuseni ithengiswa phezu kwe-counter kubantu abanoma yimuphi ubudala futhi iqukethe iphilisi elilodwa eliqukethe i-progestin, i- levonorgestrel . Kuthengiswa ngaphansi kwamagama alandelayo: Hlela B isinyathelo esisodwa , isinqumo esilandelayo esisodwa , indlela yami , ukuthatha isinyathelo , kanye ne- AfterPill .
Nakuba indlela eqondile ukuthi iphilisi elandelayo ekuseni ivimbela ukukhulelwa akucaci, ukuthi isebenza kanjani kuncike lapho ukhona kumjikelezo wakho wokuya esikhathini. Uma usukhulelwe kakade, futhi uthatha iphilisi-ekuseni ngemuva, ngeke kulimaze ukukhulelwa kwakho futhi kungabangeli ukukhipha isisu .
Iyini Ipilisi Yokukhipha Isisu?
Iphilisi yokukhipha isisu (ebizwa nangokuthi i-M & M, i-Mifeprex, i-RU486, ne-mifepristone) isetshenziselwa ukukhetha ukukhipha isisu kuqala. Kuholela ekuqedeni ukukhulelwa futhi isetshenziswe kuphela emva kokukhulelwa kusungulwe (futhi kungabi ngaphezu kwezinsuku ezingu-49 kusukela esikhathini sokugcina sokuya esikhathini sowesifazane).
Iphilisi lokukhipha isisu liqale lisetshenziswe ngokuphepha eYurophu futhi i-FDA-evunyelwe ukuba isetshenziswe e-US ngoSeptemba 2000. Iphilisi lokukhipha isisu kaningi liqukethe imithi emibili - eyodwa yokubangela uketshezi lwe-uterine ukuba luchithe (ngakho iqanda elikhulelwe lingakwazi ukuhlala linamathele) , futhi okubangela ukuba isibeletho sivumelane. Uma isetshenziselwa ndawonye, ukukhipha isisu kungu-95-97% ephumelelayo ekuqedeni ukukhulelwa.
Ngakho kungani abantu bedidekile mayelana nePill-After Pill kanye nePill Pill?
Okukhulu kwalokhu kudideka kubangelwa yizinkolelo mayelana nokuthi iphilisi elandelayo ekuseni isebenza kanjani. Hlela B isinyathelo esisodwa (kanye namanye ama-brand-morning after-brand). Ukunciphisa amathuba akho okukhulelwa ngokuvimbela noma ukulibazisa ukuvuthwa kanye / noma ngokuphazamisa ukunyakaza kwesilisa (okubangela ukuthi kungenakubalwa ukuthi insimu izodla iqanda). Ukungaboni kahle kwangempela kuhlobene nokuthi ngabe iphilisi lekusasa-ngemuva livimbela iqanda elifakwe emanzini kusuka ekutshalweni. Nakuba ucwaningo lubonisa ukuthi uhlelo lwe-B B One Step aluphazamisi ukufakelwa , ukufakwa kwe -FDA emaphilisi amuva ekuseni kusho ukuthi "kungavimbela ukufakelwa."
Kungani kubhalwe i-FDA yePill-After After Pill?
Kubonakala sengathi ucwaningo lwama-FDA olwenziwa ngesikhathi senqubo yokuvunywa kwepilisi ekuseni-emva kakhudlwana kugxile ekuphepheni nasekusebenzeni kwesithako esiyinhloko (i-progestin levonorgestrel.) Ngenxa yokuthi lolu cwaningo aluhlolisanga indlela ukusebenza ngayo iphilisi yokusa ekuseni, I-FDA ikhethe ukufaka ukuthi ingathinta ukufakelwa kwemikhiqizo ekubhalweni komkhiqizo (ikakhulukazi ngoba ukucabanga kwakungenxa yokuthi amaphilisi okulawula ukubeletha angasebenza ngokushintsha umgqa wesibeletho, iphilisi elandelayo ekuseni).
Lokho kuthiwa, i-FDA manje iyavuma ukuthi idatha ekhona kanye nocwaningo olulandelayo ngemuva kwepilisi libonisa ukuthi lo mkhiqizo awuphazamisi ukufakelwa.
Yini Abantu Abaphikisana Ngazo?
Ochwepheshe bezokwelapha kuhlanganise ne-FDA, i-American College of Obstetricians kanye namaGynecologists, kanti i-National Institutes of Health iyavuma ukuthi ukusungulwa kokukhulelwa kuthatha izinsuku ezimbalwa futhi kungagcwaliswa kuze kube khona iqanda elikhulelwe elifakwe emgqeni wesibeletho sowesifazane.
-> Ngakho - ngokwemithi, ucatshangwa ukuthi ukhulelwe emva kokufakelwa kokufakelwa.
Kodwa, abantu abaningi (kufaka hlangana ne-pro-life nezinhlangano zenkolo) bayaqhubeka babambelela enkolelweni engafanele yokuthi iphilisi ekuseni-emva ivimbela ukufakelwa kweqanda elikhulelwe.
Bashesha ukuphikisana nokusetshenziswa kwayo futhi ngokungabonakali ilebula lolu hlobo lokukhulelwa njenge-abortifacient (into ebangela ukukhulelwa ukuqeda ngaphambi kwesikhathi futhi kubangela ukukhipha isisu). Lokhu kucabanga okungalungile ukuthi iphilisi-ekuseni ngemuva kokukhipha isisu kuye kwadala umgoqo ekufinyeleleni nasekusetshenzisweni kwepilisi ekuseni . Abesifazane abanezizinda ezithile ezingokwenkolo bangase bangazibuza ngalokhu ngoba babetshelwe ukuthi kubangela ukukhipha isisu. Kukhona nezimo lapho amakamelo okuphuthumayo esibhedlela enqaba ukunikeza iphilisi ekuseni-emva kwabesifazane abadlwenguliwe.
Ngaphansi
Abagqugquzeli bephilisi ekuseni-ngemuva bahlala beqinile ngokufundisa abantu ukuthi le mithi ayisona isithunywa sokukhipha isisu. Iziphathimandla zezokwelapha zichaza ukukhipha isisu njengokuphazanyiswa kweqanda elifakwe umquba. Inqubomgomo ye-Federal, iyavumelana nomphakathi wezokwelapha futhi ichaza izidakamizwa namadivaysi asebenza ngaphambi kokufakelwa kabusha njengamalungiselelo okukhulelwa kunama-agent aqeda ukukhulelwa.
Indlela enembile yokuqonda umehluko phakathi kwala mithi emibili:
- Iphilisi yokukhipha isisu indlela yokukhipha isisu . Kuyinto evunyelwe i-FDA ukuqeda ukukhulelwa kwabesifazane abafika kumaviki angu-7 abakhulelwe.
- Iphilisi elandela ekuseni iyiluhlobo lokuphulwa kwezimo eziphuthumayo. Kuyinto evunyelwe i-FDA ukuvimbela ukukhulelwa futhi ngeke ilimaze ukukhulelwa okukhona. Ngokwemvelo, owesifazane akabhekwa sengathi ukhulelwe uma eneqanda elivundisiwe elingakasetshenziswanga esibelethweni sakhe. Lokhu kusho ukuthi akunakwenzeka ukuba iphilisi ekuseni-emva kokuqeda ukukhulelwa kusukela, ngokwemithi, ukukhulelwa akukhona.
> Imithombo:
> Marions L, Hultenby K, Lindell I, Sun X, Stabi B, & Gemzell-Danielsson K. "Ukwelashwa Okuphuthumayo Ne-Mifepristone noLevionorgestrel: Indlela Yokusebenza." I-Obstetrics and Gynecology 2002; 100 (1): 65-71.
> Prine L. "Ukukhulelwa Okuphuthumayo: Izinkolelo Neqiniso." I-Obstet Gynecol Clin N Am. 2007; 34: 127-136.